General description
Ciprofloxacin is a fluoroquinolone antibiotic
INN
Ciprofloxacin
Medicine type
Chemical agent
Antibiotic groups
EML status history
First added in 1991
(TRS
825)
for
Bacterial infection of unspecified site
Added in 2009
(TRS
958)
for
Infectious diseases of external ear
Added in 2017
(TRS
1006)
for
Infectious gastroenteritis or colitis without specification of infectious agent
Added in 2017
(TRS
1006)
for
Neutropenia
Added in 2017
(TRS
1006)
for
Peritoneal abscess
Added in 2017
(TRS
1006)
for
Peritonitis
Added in 2017
(TRS
1006)
for
Acute pyelonephritis
Added in 2017
(TRS
1006)
for
Inflammatory and other diseases of prostate
Removed in 2017
(TRS
1006)
for
Bacterial infection of unspecified site
Added in 2019
(TRS
1021)
for
Typhoid fever
Added in 2019
(TRS
1021)
for
Paratyphoid fever
Wikipedia
DrugBank
Recommendations
Section
Ear, nose and throat medicines [c]
- Local > Otological > drops: 0.3% (as hydrochloride)
Indications
Section
Watch group antibiotics
- Parenteral > General injections > IV: 2 mg per mL (as hyclate)
- Oral > Liquid: 250 mg per 5 mL (anhydrous)
- Oral > Solid: 250 mg (as hydrochloride)
- Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride); 100 mg (as hydrochloride)
- Oral > Solid: 250 mg (as hydrochloride); 500 mg (as hydrochloride)
Indications
First choice
Typhoid fever Paratyphoid fever Inflammatory and other diseases of prostate (mild to moderate) Acute pyelonephritis (mild to moderate) Neutropenia (low-risk) Infectious gastroenteritis or colitis without specification of infectious agentSecond choice
Cholera Cholera [children] co-prescribed with metronidazole Peritoneal abscess (mild-moderate) co-prescribed with metronidazole Peritonitis (mild-moderate)
Other indications